Baiao Situ - B: The first-instance judgment of patent infringement lawsuit rejected the plaintiff and Bo Medical's lawsuit request.

Bayer's announcement, the company and BoMedicine initiated a lawsuit against RenNano platform of Bayer and the antibody products obtained from the platform for patent infringement in September 2024. The Shanghai Intellectual Property Court has made a first-instance judgment, rejecting the plaintiff's and BoMedicine's lawsuit.